Cargando…
Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims
BACKGROUND: Many female breast cancer (FBC) patients take Chinese herbal medicine (CHM) and Western medication (WM) concurrently in Taiwan. Despite the possibility of interactions between the CHM and WM mentioned in previous studies, the pattern of these coprescriptions in FBC patients remains uncle...
Autores principales: | Wang, Bih-Ru, Chang, Yuh-Lih, Chen, Tzeng-Ji, Chiu, Jen-Hwey, Wu, Jing Chong, Wu, Min-Shan, Chou, Chia-Lin, Chou, Yueh-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019611/ https://www.ncbi.nlm.nih.gov/pubmed/24855343 http://dx.doi.org/10.2147/PPA.S61280 |
Ejemplares similares
-
Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan
por: Lin, Yi-Hsien, et al.
Publicado: (2012) -
Drugs Cheaper Than Threepenny: The Market of Extremely Low-Priced Drugs within the National Health Insurance in Taiwan
por: Wang, Bih-Ru, et al.
Publicado: (2014) -
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study
por: Wang, Yi-Chun, et al.
Publicado: (2016) -
Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan
por: Chang, Yuh-Lih, et al.
Publicado: (2020) -
Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)